agilon health (NYSE:AGL) Trading 5.6% Higher – Time to Buy?

agilon health, inc. (NYSE:AGL) shot up 5.6% during trading on Monday . The company traded as high as $4.21 and last traded at $4.23. 1,546,477 shares traded hands during trading, a decline of 68% from the average session volume of 4,772,640 shares. The stock had previously closed at $4.00.

Wall Street Analyst Weigh In

AGL has been the topic of a number of recent analyst reports. TD Cowen increased their price target on agilon health from $3.50 to $6.00 and gave the stock a “hold” rating in a research note on Tuesday, April 15th. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and increased their target price for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Robert W. Baird dropped their price objective on shares of agilon health from $6.00 to $5.00 and set a “neutral” rating for the company in a research report on Tuesday, April 15th. Royal Bank of Canada increased their price target on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a report on Wednesday, February 26th. Finally, Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $4.60.

agilon health Price Performance

The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The company has a market capitalization of $1.65 billion, a PE ratio of -4.26 and a beta of 0.38. The stock has a 50 day moving average price of $4.16 and a two-hundred day moving average price of $3.13.

Hedge Funds Weigh In On agilon health

Institutional investors have recently made changes to their positions in the business. Capital International Investors grew its position in agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after buying an additional 9,346,295 shares in the last quarter. Millennium Management LLC lifted its position in shares of agilon health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock worth $13,704,000 after purchasing an additional 4,706,357 shares in the last quarter. Algert Global LLC boosted its position in agilon health by 1,042.7% in the 4th quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock valued at $4,007,000 after buying an additional 1,924,157 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in agilon health by 49.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock valued at $8,629,000 after purchasing an additional 1,498,524 shares during the period. Finally, JPMorgan Chase & Co. lifted its holdings in agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after buying an additional 1,083,492 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.